nach oben

Medical Oncology

Erschienen in:

01.12.2011 | Original Paper

Central nervous system involvement in Hodgkin’s lymphoma

verfasst von: L. Galán, A. C. Sánchez, B. Cantos, M. Provencio

Erschienen in: Medical Oncology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Central nervous system involvement in Hodgkin´s lymphoma is extremely rare. We report three cases who had a relapse from the disease involving CNS. The most frequent causes are skull contiguity, meningeal invasion and via the hematogenous route. It is frequent that the association between Epstein–Barr Virus and Hodgkin´s lymphoma, and a biopsy for confirmation, is always required. Diagnostic imaging tests like CT and MRI are useful. The standard treatment remains holocraneal radiotherapy combined with chemotherapy.

Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.PubMed

Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630–6.PubMed

De Vita VT, Serpick A. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Proc Amer Ass Cancer Res. 1967;8:13.

Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 1975;36:252–9.PubMedCrossRef

Kaplan HS, Rosenberg SA. Extended field radical radiotherapy in advanced Hodgkin’s disease. Cancer Res. 1966;26:1268–76.PubMed

Aragón de la Cruz G, Cardenes H, Otero J, et al. Individual risk of abdominal disease in patients with stages I and II supradiaphragmatic Hodgkin’s disease a rule index based on 341 laparotomized patients. Cancer. 1989;63:1799–803.PubMedCrossRef

Johnson MD, Kinney MC, Scheithauer BW, Briley RJ, Hamilton K, Mc Person WF, Barton JH Jr. Primary intracerebral Hodgkin’s disease mimicking meningioma: Case report. Neurosurgery. 2000;47(2):454–6.PubMedCrossRef

Cuttner J, Meyer R, Huang YP. Intracerebral involvement in Hodgkin’s disease: A report of 6 cases and review of the literature. Cancer. 1979;43(4):1497–506.PubMedCrossRef

Biagi J, MacKenzie R, Lim MS, Sapp M, Berinstein N. Primary Hodgkin’s disease of the CNS in an immunocompetent patient: A case study review of the literature. Neuro-Oncology. 2000;2(4):239–43.PubMed

10.

Hirmiz K, Foyle A, Wilke D, Burrell S, Brownstone R, Ago C, et al. Intracranial presentation of systemic Hodgkin’s disease. Leukemia, Lymphoma. 2004;45(8):1667–71.CrossRef

11.

Sapozink MD, Kaplan HS. Intracraneal Hodgkin’s disease: A report of 12 cases and review of the literature. Cancer. 1983;52:1301–7.PubMedCrossRef

12.

Alvarez F, Road JM, Ancines B, Alvarez MP. Intracranial Hodgkin disease. J Neurosurg Sci. 1985;29:273–7.PubMed

13.

Ogata H, Karikomi M, Araki T, Uchiyama GA. Case of intracranial involvement of Hodgkin disease. Radiat Med. 1993;11:210–3.PubMed

14.

Klein R, Mullges W, Bendszus M, et al. Primary intracerebral Hodgkin’s disease: Report of a case with Epstein-Barr virus association and review of the literature. Am J Surg Pathol. 1999;23:477–81.PubMedCrossRef

15.

Apollonsky N, Edelman M, Johnson A, et al. Intracerebral presentation of Hodgkin disease mimicking meningioma in a young woman. J Pediatr Hematol Oncol. 2008;30:369–72.PubMedCrossRef

16.

Pansegrau, et al. Hodgkin’s Lymphoma involving the CNS. J Clin Oncol. 2007;25(11):1437–8.CrossRef

17.

Guermazi A, Brice P, Kerviler E, et al. Extranodal Hodgkin disease: Spectrum of disease. RadioGraphics. 2001;21:161–79.PubMed

18.

Blake PR, Carr DH, Goolden AW. Intracranial Hodgkin’s disease. Br J Radiol. 1986;59:414–6.PubMedCrossRef

19.

Marshall G, Roessmann V, van den Noort S. Invasive Hodgkin’s disease of the brain. Report of 2 new cases and review of the American and European literature with clinical-pathological correlation. Cancer. 1968;2:621–30.CrossRef

20.

Kaufman G. Hodgkin’s disease involving the central nervous system. Arch Neurol. 1965;13:555–8.PubMedCrossRef

21.

Orlowski EP, Hansen RM, Anderson T, Hanson GA, Kun LE, Pisciotta AV. Hodgkin disease with leptomeningeal involvement, report of a case with long survival. Cancer. 1984;53:1833–5.PubMedCrossRef

22.

Chim CS, Shek TW, Ooi GC, Liang R. Unusual features of Hodgkin disease. Case 2: Meningeal relapse in Hodgkin disease. J Clin Oncol. 2000;18:1153–5.PubMed

23.

Vera R, Enriquez R, Papc R. Hodgkin’s disease, intracraneal involvement. Report of a case and review of the literature. Am J Clin Oncol. 1985;8:73–6.PubMedCrossRef

Titel: Central nervous system involvement in Hodgkin’s lymphoma
verfasst von: L. Galán
A. C. Sánchez
B. Cantos
M. Provencio
Publikationsdatum: 01.12.2011
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe Sonderheft 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-010-9692-z

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Central nervous system involvement in Hodgkin’s lymphoma

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2011

Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population

Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia

Clear cell odontogenic carcinoma: report of 6 cases and review of the literature

Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas

CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients

Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie